- Innoviva press release ( NASDAQ: INVA ): Q3 GAAP EPS of $2.80.
- Revenue of $67.26M (-31.3% Y/Y).
For further details see:
Innoviva GAAP EPS of $2.80, revenue of $67.26MFor further details see:
Innoviva GAAP EPS of $2.80, revenue of $67.26MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strate...